BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31631559)

  • 21. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2/STAT3 signaling pathway.
    Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
    Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.
    Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Lin B; Wang H; Zou D; Zhou Z; Xu J; Yi C; Cai Z
    Cell Death Dis; 2016 Oct; 7(10):e2421. PubMed ID: 27735939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
    Wang W; Chen D; Zhu K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):37. PubMed ID: 29475441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway.
    Xie T; Ren HY; Lin HQ; Mao JP; Zhu T; Wang SD; Ye ZM
    Int J Oncol; 2016 May; 48(5):2098-112. PubMed ID: 26983669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
    Wang L; Xue GB
    Biochem Biophys Res Commun; 2018 Jan; 495(1):27-34. PubMed ID: 29032182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells.
    Zuo D; Shogren KL; Zang J; Jewison DE; Waletzki BE; Miller AL; Okuno SH; Cai Z; Yaszemski MJ; Maran A
    J Exp Clin Cancer Res; 2018 Oct; 37(1):244. PubMed ID: 30286779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway.
    Wang W; Li J; Ding Z; Li Y; Wang J; Chen S; Miao J
    J Cell Mol Med; 2019 Sep; 23(9):6454-6465. PubMed ID: 31293090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induced by bruceine D in human non‑small‑cell lung cancer cells involves mitochondrial ROS‑mediated death signaling.
    Xie JH; Lai ZQ; Zheng XH; Xian YF; Li Q; Ip SP; Xie YL; Chen JN; Su ZR; Lin ZX; Yang XB
    Int J Mol Med; 2019 Dec; 44(6):2015-2026. PubMed ID: 31638181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
    Wang X; Goldstein D; Crowe PJ; Yang JL
    Anticancer Res; 2014 Nov; 34(11):6537-45. PubMed ID: 25368256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effect and significance of rapamycin on the mammalian target of rapamycin signaling pathway in osteosarcoma stem cells and osteosarcoma cells].
    Liu PY; Zhang WB; Wang J; Shen YH; Wei YY
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):175-80. PubMed ID: 23879996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costunolide inhibits osteosarcoma growth and metastasis via suppressing STAT3 signal pathway.
    Jin X; Wang C; Wang L
    Biomed Pharmacother; 2020 Jan; 121():109659. PubMed ID: 31739161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/NOTCH1 signaling.
    Wei D; Zhu X; Li S; Liu G; Wang Y; Wang W; Zhang Q; Jiang S
    Biochem Biophys Res Commun; 2021 May; 554():206-213. PubMed ID: 33813076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.